Suppr超能文献

肝切除术治疗复杂肝细胞癌:长期生存的挑战与机遇。

Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-term survivals.

机构信息

Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

J Surg Oncol. 2012 Dec;106(8):959-65. doi: 10.1002/jso.23172. Epub 2012 May 30.

Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is often diagnosed late because of the lack of pathognomonic symptoms. This study evaluated outcomes following liver resection (LR) for patients with HCC presenting with large tumor size (over 10 cm), adjacent organ invasion, or ruptured tumor, which we termed as complicated HCC (cHCC).

MATERIALS AND METHODS

We retrospectively reviewed 660 HCC patients who underwent LR between January 2001 and July 2005. The patients were grouped into cHCC and non-cHCC according to the defined criteria. The clinicopathological features were analyzed and compared between the two groups.

RESULTS

Patients in the cHCC group required longer operative times and resulted in greater intraoperative blood loss and more severe surgical complications. The cHCC group had a higher incidence of HCC recurrence after LR, and the HCC recurrence had a tendency to be associated with extrahepatic metastasis. The 5-year RFS (P < 0.0001) and OS (P < 0.0001) of cHCC and non-cHCC patients were 18.5% and 28.9% versus 37.5% and 57.6%, respectively.

CONCLUSIONS

LR for cHCC can be a great challenge for liver surgeons. However, with comparable operative mortality rates and acceptable survival times, surgical resection should always be considered performing in patients with cHCC, if clinically feasible.

摘要

背景

由于缺乏特征性症状,肝细胞癌 (HCC) 常常在晚期被诊断出来。本研究评估了对于肿瘤直径大于 10cm、临近器官侵犯或肿瘤破裂的 HCC 患者(我们将其称为复杂 HCC [cHCC])行肝切除术 (LR) 后的结果。

材料和方法

我们回顾性分析了 2001 年 1 月至 2005 年 7 月期间接受 LR 的 660 例 HCC 患者。根据定义的标准,患者被分为 cHCC 和非-cHCC 组。分析并比较了两组的临床病理特征。

结果

cHCC 组的手术时间更长,术中出血量更大,手术并发症更严重。cHCC 组 LR 后 HCC 复发的发生率更高,且 HCC 复发有向肝外转移的趋势。cHCC 和非-cHCC 患者的 5 年 RFS(P<0.0001)和 OS(P<0.0001)分别为 18.5%和 28.9%与 37.5%和 57.6%。

结论

对于 HCC 患者而言,LR 可能是肝脏外科医生面临的巨大挑战。然而,如果临床可行,手术切除应始终被视为治疗 cHCC 患者的一种选择,因为其手术死亡率相当,生存时间也可接受。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验